Key Financial Data Of Group

Cyfuse Biomedical K.K. - Filing #7546761

Concept As at
2023-06-30
2023-01-01 to
2023-06-30
2023-04-01 to
2023-06-30
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-06-30
2022-04-01 to
2022-06-30
2022-01-01 to
2022-06-30
Key financial data of group
Business results of group
Net sales
18,272,000 JPY
374,477,000 JPY
332,504,000 JPY
Ordinary profit (loss)
-362,953,000 JPY
-433,165,000 JPY
-76,127,000 JPY
Net assets
3,410,644,000 JPY
3,769,801,000 JPY
1,900,975,000 JPY
Total assets
4,386,406,000 JPY
4,815,337,000 JPY
2,850,391,000 JPY
Basic earnings (loss) per share
-46.73
-25.16
-177.67
-185.42
-203.61
Diluted earnings per share
Equity-to-asset ratio
0.777 xbrli:pure
0.783 xbrli:pure
0.666 xbrli:pure
Net cash provided by (used in) operating activities
-315,940,000 JPY
-403,596,000 JPY
-43,463,000 JPY
Net cash provided by (used in) investing activities
-11,347,000 JPY
-430,674,000 JPY
-260,726,000 JPY
Net cash provided by (used in) financing activities
-53,418,000 JPY
2,658,538,000 JPY
319,145,000 JPY
Cash and cash equivalents
3,056,601,000 JPY
3,437,307,000 JPY
1,627,996,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.